Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand
View Session Discussion + Q&A

Epi & Infection Control

Investigative ID

Pediatric ID

Trainee

Transplant
Session Type: Debate-Style Session

5 - Mano-a-Mano​

Sunday, October 19, 2025
1:30 PM - 3:15 PM US ET
Location: B405-B407

Live Streamed On Demand
CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
CNE Credits: Maximum of 1.75 hours of ANCC Credit
ACPE Credits: ACPE 1.75 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 2 of PACE contact hours
CE Broker: Maximum of 2 CE broker credit hours
Disclosure(s):
Latania K. Logan, MD, MSPH: No financial relationships to disclose.
Katie Chiotos, MD MSCE: No financial relationships to disclose.
Angie Myers, MD, MPH: No financial relationships to disclose.
Andi L. Shane, MD, MPH, MSc: Pediatric Infectious Diseases Society: Stipend to serve as the Deputy Editor of JPIDS
Rebecca Same, MD: No financial relationships to disclose.
Scott James, MD: Evrys: Grant/Research Support; Gilead Biosciences: Grant/Research Support; IntegerBio: Grant/Research Support
Terri Stillwell, MD, MPH: No financial relationships to disclose.
Zach Willis, MD, MPH: Merck and Company, Inc.: Grant/Research Support; Pfizer, Inc.: Grant/Research Support

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • describe evidence-based data to inform decisions regarding the use of ceftriaxone for invasive MSSA;
  • describe available data to inform whether nitazoxanide is warranted in immunocompromised patients with diarrhea and positive norovirus tests;
  • describe if and when the length of PID fellowship should be changed.

Presentations:

  • 1:30 PM - 1:48 PM US ET
    Ceftriaxone Can Be Used for Invasive MSSA Infections - Pro

    Debate Style Speaker: Zach Willis, MD, MPH (he/him/his) – Univ. North Carolina Chapel Hill

  • 1:48 PM - 2:05 PM US ET
    Ceftriaxone Should Not Be Used for Invasive MSSA Infections - Con

    Debate Style Speaker: Rebecca Same, MD (she/her/hers) – Children's Hospital of Philadelphia

  • 2:05 PM - 2:20 PM US ET
    Nitazoxanide Should Be Used for Pediatric Immunocompromised Hosts With Severe or Prolonged Diarrhea and Positive Norovirus Test - Pro

    Debate Style Speaker: Andi L. Shane, MD, MPH, MSc (she/her/hers) – Emory University School of Medicine and Children's Healthcare of Atlanta

  • 2:20 PM - 2:40 PM US ET
    Nitazoxanide Should Not Be Used for Pediatric Immunocompromised Hosts With Severe or Prolonged Diarrhea and Positive Norovirus Test - Con

    Debate Style Speaker: Terri Stillwell, MD, MPH (she/her/hers) – Univ of Pittsburgh

  • 2:40 PM - 2:57 PM US ET
    Pediatric Infectious Diseases Fellowship Should Be Two Years

    Debate Style Speaker: Angie Myers, MD, MPH (she/her/hers) – Children's Mercy Kansas City

  • 2:57 PM - 3:15 PM US ET
    Pediatric Infectious Diseases Fellowship Should Be Three Years

    Debate Style Speaker: Scott James, MD – University of Alabama at Birmingham